Posted on: 10 July, 2023
Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 14 February, 2023
We are pleased to announce the successful recipients of our annual Kolling Institute awards program.
Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling.
The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well as overall a.....
Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research
Posted on: 13 February, 2023
We would like to congratulate Professor Carol Pollock who has received a highly prestigious award for her extraordinary commitment to research.
The International Society of Nephrology has announced Professor Pollock is the 2023 recipient of the Alfred Newton Richards award for outstanding research in the field of nephrology.
Carol has welcomed the news.
“I am extremely honoured to be recognised by .....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 20 December, 2022
Congratulations to Kolling Institute researcher and Royal North Shore Hospital cardiologist Dr Steve Vernon who’s been awarded a highly sought-after postdoctoral fellowship by the Heart Foundation.
The fellowship is designed to support talented early career researchers and emerging leaders.
Dr Vernon has welcomed the award.
“I am delighted to receive this postdoctoral funding from the Heart Foundat.....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 07 December, 2022
Generous funding provided through the Douglas and Lola Douglas scholarship is strengthening evidence around the long term impacts on children born to mothers with obesity and gestational diabetes.
Endocrinologist and Kolling Institute researcher Dr Tessa Weir has been able to continue her valuable research as a result of being awarded the scholarship.
“I am incredibly grateful for the support .....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 11 November, 2022
Kolling researcher and Royal North Shore Hospital endocrinologist Associate Professor Sarah Glastras will have a key role in a national effort to improve long-term outcomes for those with diabetes.
The initiative has brought dozens of experts from across the country together under the banner of the Australian Centre for Accelerating Diabetes Innovations Research.
International collaborators will al.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 19 October, 2022
Kolling Institute researcher and RNSH Senior Hospital Scientist Dr Anastasia Mihailidou says she was delighted to showcase the district’s work in blood pressure management on the world stage.
Dr Mihailidou, who is head of the Kolling’s Cardiovascular and Hormonal Research Lab, presented at the recent International Society of Hypertension Scientific Meeting in Japan.
Globally renowned academics and .....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 17 October, 2022
We would like to congratulate Professors Carol Pollock and Gemma Figtree who have received significant National Health and Medical Research Council Investigator Grants.
Despite a tremendously competitive field, both clinician/researchers have been awarded $2 million to progress their world-leading research and improve long-term patient outcomes.
The announcement highlights the experience and expert.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 16 September, 2022
Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock.
Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme.
The listing aims to help those with the condition by.....
Read more
Category: Cardiovascular and Renal Research, New Treatment
Posted on: 26 August, 2022
With a disturbing number of people losing their lives to heart disease each year, researchers have launched the first study of its kind using MRI technology to broaden our understanding of the link between cardiovascular disease and sleep apnoea.
The project has been made possible following funding from the Ramsay Research Grant Program, and will involve clinician researchers from Northern Sydney L.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence